Watchlist Price Alert

Aurinia Pharmaceuticals I... (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

7.93

-0.21 (-2.58%)

At close: Jun 17, 2025, 3:59 PM

7.91

-0.32%

After-hours: Jun 17, 2025, 04:20 PM EDT

Aurinia Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	235.13M	175.51M	134.03M	45.6M	50.12M	318K	463K	420K	173K
Cost of Revenue	28.25M	14.15M	5.66M	1.09M	50.33M	52.87M	41.38M	1K	4K
Gross Profit	206.88M	161.37M	128.37M	44.51M	-209K	-52.55M	-40.92M	419K	169K
Operating Income	-4.69M	-91.69M	-111.47M	-180.74M	-104.29M	-82.54M	-56.16M	-47.06M	-22.81M
Interest Income	16.97M	17M	5.12M	529K	1.52M	2.7M	2.23M	1.04M	27K
Pretax Income	7.45M	-77.47M	-106.35M	-180.21M	-102.77M	-123.7M	-64.05M	-70.79M	-23.3M
Net Income	5.75M	-78.02M	-108.18M	-180.97M	-102.68M	-123.85M	-64.12M	-70.79M	-23.3M
Selling & General & Admin	172.03M	195.04M	196.37M	171.44M	95.98M	22.15M	13.67M	12.1M	6.97M
Research & Development	20.79M	49.64M	44.99M	51.14M	50.33M	52.87M	41.38M	33.93M	14.53M
Other Expenses	18.76M	8.38M	-1.52M	2.67M	1.29M	1.55M	2.06M	195K	-1.63M
Operating Expenses	211.57M	253.06M	239.84M	225.25M	147.6M	76.57M	56.62M	47.48M	22.98M
Interest Expense	4.83M	2.77M	5.12M	n/a	n/a	39K	2.23M	702K	27K
Selling & Marketing Expenses	14.09M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	239.82M	267.2M	245.5M	226.34M	147.6M	76.57M	56.62M	47.48M	22.99M
Income Tax Expense	1.7M	551K	1.83M	760K	-94K	144K	73K	23.92M	481K
Shares Outstanding (Basic)	143.06M	143.24M	141.91M	129.37M	118.47M	93.02M	84.78M	76.92M	35.28M
Shares Outstanding (Diluted)	146.19M	143.24M	141.91M	129.37M	118.47M	93.02M	84.78M	76.95M	35.28M
EPS (Basic)	0.04	-0.54	-0.76	-1.4	-0.87	-1.33	-0.76	-0.92	-0.66
EPS (Diluted)	0.04	-0.54	-0.76	-1.4	-0.87	-1.33	-0.76	-0.92	-0.66
EBITDA	31.73M	-63.05M	-103.65M	-177.44M	-102.92M	-89.77M	-53.93M	-45.61M	-21.34M
EBIT	12.28M	-74.69M	-106.35M	-180.21M	-104.29M	-90.94M	-55.91M	-47.06M	-22.81M
Depreciation & Amortization	19.45M	11.65M	2.71M	2.76M	1.37M	1.17M	1.56M	1.46M	1.48M